Limited-Time September Offer: Try 7 Days for Free

Idexx Laboratories (IDXX) Stock Price

$641.1 0%

Sign up
to add to portfolio

AI Score

  • Alternative

    5
  • Fundamental

    9
  • Technical

    6

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.

Sign up to get access to more historical data and insights on Idexx Laboratories, AI stock picks, stock alerts and much more.

Sign up

IDXX AI Stock Analysis

AI stock analysis for IDXX is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Idexx Laboratories (IDXX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Idexx Laboratories (IDXX) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Idexx Laboratories (IDXX), currently trading at $641.1, will... Sign up to access price prediction.

About IDXX

LSE
  • IDEXX Laboratories, Inc.

  • Symbol

    IDXX

  • Market

    NASDAQ

  • Industry

    Medical - Diagnostics & Research

  • Market Cap

    51.3B

Similar Stocks

BNGO Bionano Genomics
BNGO
$3.88
4.4%
4
ILMN Illumina
ILMN
$95.12
4.2%
5
NEOG Neogen
NEOG
$5.5
4.2%
4
DRIO DarioHealth
DRIO
$7.11
0.3%
4
GH Guardant Health
GH
$54.9
3.4%
6

IDXX Alternative Data

Web Traffic

Idexx Laboratories receives an estimated 642178 monthly visitors to idexx.com, which is down by -12% over the last month.

  • Web Traffic

    642178

  • Change from Previous Month

    12%

  • 3 Month Change

    11.4%

  • YoY Change

    11.4%

Twitter Followers

Idexx Laboratories has 267 Twitter Followers on its main Twitter (also known as X) account.

  • Twitter Followers

    267

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0.4%

  • YoY Change

    0.4%

Facebook Engagement

Idexx Laboratories has engaged 264 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    264

  • Daily Change

    13.4%

  • 1 Month Change

    54.7%

  • 3 Month Change

    77.1%

  • YoY Change

    77.1%

Instagram Followers

Idexx Laboratories has 20,088 Instagram Followers on its main Instagram account, up by 0.9% over the last month.

  • Instagram Followers

    20088

  • Daily Change

    0%

  • 1 Month Change

    0.9%

  • 3 Month Change

    2.9%

  • YoY Change

    2.9%

Youtube Subscribers

Idexx Laboratories has 5,470 subscribers on its main Youtube channel, up by 0.6% over the last month.

  • Youtube Subscribers

    5470

  • Daily Change

    0%

  • 1 Month Change

    0.6%

  • 3 Month Change

    1.9%

  • YoY Change

    1.9%

LinkedIn Followers

221,284 are following Idexx Laboratories on LinkedIn, up by 1.4% over the last month.

  • LinkedIn Followers

    221284

  • Daily Change

    0%

  • 1 Month Change

    1.4%

  • 3 Month Change

    4.4%

  • YoY Change

    4.4%

Job Postings

Idexx Laboratories has an estimated 167 open job postings, which is down -16.5% over the last month.

  • Job Postings

    167

  • Daily Change

    0%

  • 1 Month Change

    16.5%

  • 3 Month Change

    5.1%

  • YoY Change

    5.1%

LinkedIn Employees

According to LinkedIn, Idexx Laboratories has 7,740 employees, up by 0.3% over the last month.

  • LinkedIn Employees

    7740

  • Daily Change

    0%

  • 1 Month Change

    0.3%

  • 3 Month Change

    1%

  • YoY Change

    1%

Reddit Mentions

Idexx Laboratories has been mentioned an estimated 4 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    4

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Business Outlook

According to employee reviews, the business outlook among employees at Idexx Laboratories is 59 out of 100 (neutral), down by -1.7% over the last month.

  • Business Outlook

    59

  • Change from Previous Month

    1.7%

  • 3 Month Change

    0%

  • YoY Change

    0%

News Mentions

Idexx Laboratories was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

IDXX Financials

IDXX Key Metrics
  • Total Revenue

    $998.4M

  • Net Income

    $242.7M

  • Earnings per Share

    $2.94

  • Free cash flow

    $207.9M

  • EBITDA

    $316.5M

  • EBITDA Ratio

    0.317033

  • Total Assets

    $3.2B

IDXX 2-year Revenue & Income
IDXX 2-year Free Cash Flow

IDXX Technicals

IDXX SMA
IDXX RSI

FAQ

What's the current price of Idexx Laboratories (IDXX) Stock?
The price of an Idexx Laboratories (IDXX) share is $641.1.

What's the market cap of Idexx Laboratories?
The current market cap of Idexx Laboratories is 51.3B.

What are some stocks similar to Idexx Laboratories (IDXX) that investors often compare it to?
Idexx Laboratories (IDXX) is often compared to similar stocks such as Bionano Genomics, Illumina, Neogen, DarioHealth and Guardant Health.

What is the forecast for Idexx Laboratories' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Idexx Laboratories' stock price to be around $662.1 in 2026. Starting from the current price of $641.1, this represents a 3.3% change in price, indicating a neutral outlook for the stock.

How to buy Idexx Laboratories (IDXX) Stock?
Idexx Laboratories stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Idexx Laboratories shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.